Needham increased its price target for UiPath Inc. to $22 from $15 while maintaining a buy rating, citing the company’s expanding AI exposure and premium customer growth. The firm also noted UiPath’s valuation at roughly 13 times enterprise value to free cash flow based on fiscal 2029 and calendar 2028 targets.
UiPath’s shares, which have risen 65% over the past year, were trading near $18.15 late last month. The company is scheduled to report earnings on September 3, with Bloomberg options data indicating an estimated 11% potential stock swing following the announcement. Historically, UiPath has beaten implied option movements in two of its last eight earnings reports.
Needham highlighted bullish factors including strong process automation capabilities, accelerating client adoption in the premium segment, and robust free cash flow growth. The firm also pointed to UiPath’s 83% gross profit margin and current liquidity ratio of 2.31 as supportive metrics. UBS separately raised its price target to $19 from $12 while maintaining a neutral stance.
The analyst commentary follows UiPath’s launch of Maestro Case, an AI-native case management tool integrated into its Maestro business orchestration platform. The capability is designed to coordinate AI agents, robotic process automation, human workflows, applications, and data within enterprise processes. Needham’s upgrade aligns with broader expectations for AI-driven productivity gains in enterprise software, though bears warn of potential AI adoption delays and intensifying competition from vertical vendors and frontier model providers.
Bearish risks cited include concerns over AI paralysis, competition from internally developed solutions, and a potential deceleration in net annual recurring revenue growth to below 10% in the second half of 2027.
